Joint symptoms, aromatase inhibitor-related adverse reactions, are indirectly associated with decreased serum estradiol.
about
The JACS prospective cohort study of newly diagnosed women with breast cancer investigating joint and muscle pain, aches, and stiffness: pain and quality of life after primary surgery and before adjuvant treatment.The time since last menstrual period is important as a clinical predictor for non-steroidal aromatase inhibitor-related arthralgia.Endocrine Treatment-Related Symptoms and Patient Outcomes in Breast Cancer: A Meta-Analysis.
P2860
Joint symptoms, aromatase inhibitor-related adverse reactions, are indirectly associated with decreased serum estradiol.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Joint symptoms, aromatase inhi ...... ith decreased serum estradiol.
@ast
Joint symptoms, aromatase inhi ...... ith decreased serum estradiol.
@en
type
label
Joint symptoms, aromatase inhi ...... ith decreased serum estradiol.
@ast
Joint symptoms, aromatase inhi ...... ith decreased serum estradiol.
@en
prefLabel
Joint symptoms, aromatase inhi ...... ith decreased serum estradiol.
@ast
Joint symptoms, aromatase inhi ...... ith decreased serum estradiol.
@en
P2093
P2860
P356
P1476
Joint symptoms, aromatase inhi ...... ith decreased serum estradiol.
@en
P2093
Akira Tangoku
Junko Honda
Masako Takahashi
Misako Nakagawa
Mitsunori Sasa
Miyuki Kanematsu
Taeko Nagao
P2860
P304
P356
10.1155/2011/951260
P577
2011-05-26T00:00:00Z